Cargando…
Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans
The object of this study was to test whether posaconazole, a broad-spectrum antifungal agent inhibiting ergosterol biosynthesis, exhibits synergy with the β-1,3 glucan synthase inhibitor caspofungin or the calcineurin inhibitor FK506 against the human fungal pathogen Candida albicans. Although curre...
Autores principales: | Chen, Ying-Lien, Lehman, Virginia N., Averette, Anna F., Perfect, John R., Heitman, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589401/ https://www.ncbi.nlm.nih.gov/pubmed/23472097 http://dx.doi.org/10.1371/journal.pone.0057672 |
Ejemplares similares
-
Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond
por: Rivera, Angela, et al.
Publicado: (2023) -
Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
por: Victorio, Gerardo Becerra, et al.
Publicado: (2017) -
Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit In Vivo Therapeutic Efficacy against Cryptococcus
por: Hoy, Michael J., et al.
Publicado: (2022) -
Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents
por: Juvvadi, Praveen R., et al.
Publicado: (2019) -
Development of Non-Immunosuppressive FK506 Derivatives as Antifungal and Neurotrophic Agents
por: Jung, Jin A, et al.
Publicado: (2020)